310
Participants
Start Date
December 16, 2024
Primary Completion Date
February 1, 2027
Study Completion Date
February 1, 2027
RO7759065
Specified dose on specified days
Atezolizumab
Specified dose on specified days
St Vincent's Hospital Sydney, Darlinghurst
Clinica Universidad de Navarra-Madrid, Madrid
Clinica Universidad de Navarra, Pamplona
Hospital Clinico Universitario de Valencia, Valencia
City of Hope Comprehensive Cancer Center, Duarte
University of Colorado, Aurora
Rutgers Cancer Institute of New Jersey, New Brunswick
Tennesse Oncology - NASH - SCRI - PPDS, Chattanooga
British Columbia Cancer Agency, Vancouver
Princess Margaret Cancer Centre, Toronto
Sir Mortimer B Davis Jewish General Hospital-3755 Cote Sainte-Catherine, Montreal
Lead Sponsor
Genentech, Inc.
INDUSTRY